Fractyl Health, Inc. Depreciation
Fractyl Health, Inc. (GUTS) reported Depreciation of $559.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-10
- Fractyl Health, Inc. depreciation for the quarter ending 2026-06-30 was $278.00K, a 2.96% increase year-over-year.
- Fractyl Health, Inc. depreciation for the quarter ending 2026-03-31 was $281.00K, a 3.10% decline year-over-year.
- Fractyl Health, Inc. depreciation for the quarter ending 2025-12-31 was $279.00K, a 25.11% increase year-over-year.
- Fractyl Health, Inc. depreciation for the quarter ending 2025-09-30 was $290.00K, a 38.76% increase year-over-year.
- Fractyl Health, Inc. depreciation for fiscal 2025 was $1.13M, a 66.77% increase from fiscal 2024.
- Fractyl Health, Inc. depreciation for fiscal 2024 was $677.00K, a 136.71% increase from fiscal 2023.
- Fractyl Health, Inc. depreciation for fiscal 2023 was $286.00K.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $278.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $559.00K 10-Q · filed 2026-08-10 | $838.00K derived: sum of 3 quarters · filed 2026-08-10 | $1.13M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $281.00K 10-Q · filed 2026-05-12 | $560.00K derived: sum of 2 quarters · filed 2026-05-12 | $850.00K derived: sum of 3 quarters · filed 2026-05-12 | $1.12M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $279.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $569.00K derived: sum of 2 quarters · filed 2026-03-24 | $839.00K derived: sum of 3 quarters · filed 2026-08-10 | $1.13M 10-K · filed 2026-03-24 |
| 2025-09-30 | $290.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $560.00K derived: sum of 2 quarters · filed 2026-08-10 | $850.00K 10-Q · filed 2025-11-12 | $1.07M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $270.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $560.00K 10-Q · filed 2026-08-10 | $783.00K derived: sum of 3 quarters · filed 2026-08-10 | $992.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $290.00K 10-Q · filed 2026-05-12 | $513.00K derived: sum of 2 quarters · filed 2026-05-12 | $722.00K derived: sum of 3 quarters · filed 2026-05-12 | $914.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $223.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $432.00K derived: sum of 2 quarters · filed 2026-03-24 | $624.00K derived: sum of 3 quarters · filed 2026-03-24 | $677.00K 10-K · filed 2026-03-24 |
| 2024-09-30 | $209.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $401.00K derived: sum of 2 quarters · filed 2025-11-12 | $454.00K 10-Q · filed 2025-11-12 | $492.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $192.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $245.00K 10-Q · filed 2025-08-12 | $283.00K derived: sum of 3 quarters · filed 2025-08-12 | $367.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $53.00K 10-Q · filed 2025-05-13 | $91.00K derived: sum of 2 quarters · filed 2025-05-13 | $175.00K derived: sum of 3 quarters · filed 2025-05-13 | $259.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $122.00K derived: sum of 2 quarters · filed 2025-03-03 | $206.00K derived: sum of 3 quarters · filed 2025-03-03 | $286.00K 10-K · filed 2025-03-03 |
| 2023-09-30 | $84.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $168.00K derived: sum of 2 quarters · filed 2024-11-12 | $248.00K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $84.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $164.00K 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | $80.00K 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |